PTC Therapeutics (PTCT) free cash flow

Free cash flow · fiscal 2025
$411.18M

PTC Therapeutics (PTCT) generated free cash flow of $411.18M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$181.94M. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$411.18M
Highest on record
$411.18Mfiscal 2025
Lowest on record
-$509.11Mfiscal 2022
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

PTC Therapeutics free cash flow, in more detail

Across the 15 fiscal years on record (2011–2025), the highest was $411.18M in fiscal 2025 and the lowest -$509.11M in fiscal 2022.

History · 15 fiscal years

Free cash flow by fiscal year

PTC Therapeutics free cash flow, year by year

PTC Therapeutics (PTCT) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$411.18M—
2024-$181.94M—
2023-$279.04M—
2022-$509.11M—
2021-$279.55M—
2020-$211.91M—
2019-$112.40M—
2018-$34.74M—
2017-$13.16M—
2016-$105.34M—
2015-$127.06M—
2014-$61.94M—
2013-$47.77M—
2012-$48.12M—
2011-$20.93M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of PTC Therapeutics and comparable companies
CompanyFree cash flowFiscal year
BillionToOne BLLN$15.67M2025
Hims & Hers Health HIMS$57.42M2025
PTC Therapeutics PTCT$411.18M2025
Haemonetics HAE$260.44M2026
Erasca ERAS-$105.08M2025
Concentra Group Holdings Parent CON$197.06M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTCT

PTC Therapeutics, figure by figure

PTC Therapeutics (PTCT) overview: price, valuation and scorecardAll health care companies by market value

PTC Therapeutics free cash flow: questions and answers

What is PTC Therapeutics's free cash flow?

PTC Therapeutics (PTCT) generated free cash flow of $411.18M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$181.94M.

What are the highest and lowest free cash flow figures on record for PTC Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $411.18M in fiscal 2025 and the lowest -$509.11M in fiscal 2022.

How is PTC Therapeutics's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For PTC Therapeutics it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PTC Therapeutics (PTCT) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/PTCT/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.